» Articles » PMID: 29685888

The Type III Secretion Translocator PopB Assists the Insertion of the PopD Translocator into Host Cell Membranes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Apr 25
PMID 29685888
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Many Gram-negative bacterial pathogens use a type III secretion system to infect eukaryotic cells. The injection of bacterial toxins or protein effectors via this system is accomplished through a plasma membrane channel formed by two bacterial proteins, termed translocators, whose assembly and membrane-insertion mechanisms are currently unclear. Here, using purified proteins we demonstrate that the translocators PopB and PopD in assemble heterodimers in membranes, leading to stably inserted hetero-complexes. Using site-directed fluorescence labeling with an environment-sensitive probe, we found that hydrophobic segments in PopD anchor the translocator to the membrane, but without adopting a typical transmembrane orientation. A fluorescence dual-quenching assay revealed that the presence of PopB changes the conformation adopted by PopD segments in membranes. Furthermore, analysis of PopD's interaction with human cell membranes revealed that PopD adopts a distinctive conformation when PopB is present. An N-terminal region of PopD is only exposed to the host cytosol when PopB is present. We conclude that PopB assists with the proper insertion of PopD in cell membranes, required for the formation of a functional translocon and host infection.

Citing Articles

Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal infection via inhibition of toxin translocation by the type III secretion system.

Numata S, Hara T, Izawa M, Okuno Y, Sato Y, Yamane S Antimicrob Agents Chemother. 2024; 68(10):e0069424.

PMID: 39269189 PMC: 11459929. DOI: 10.1128/aac.00694-24.


Human Saposin B Ligand Binding and Presentation to α-Galactosidase A.

Sawyer T, Aral E, Staros J, Bobst C, Garman S bioRxiv. 2024; .

PMID: 38617236 PMC: 11014568. DOI: 10.1101/2024.04.04.584535.


The sequence of events of enteropathogenic . 's type III secretion system translocon assembly.

Gershberg J, Morhaim M, Rostrovsky I, Eichler J, Sal-Man N iScience. 2024; 27(3):109108.

PMID: 38375228 PMC: 10875159. DOI: 10.1016/j.isci.2024.109108.


Macrophage innate immune responses delineate between defective translocon assemblies produced by YopD mutants.

Farag S, Francis M, Gurung J, Nyunt Wai S, Stenlund H, Francis M Virulence. 2023; 14(1):2249790.

PMID: 37621095 PMC: 10461508. DOI: 10.1080/21505594.2023.2249790.


Quercetin Attenuates the Production of Pro-Inflammatory Cytokines in H292 Human Lung Epithelial Cells Infected with by Modulating ExoS Production.

Ahn H, Jang H, Kwon O, Kim J, Oh J, Kim S J Microbiol Biotechnol. 2023; 33(4):430-440.

PMID: 36788468 PMC: 10164726. DOI: 10.4014/jmb.2208.08034.


References
1.
Engel J, Balachandran P . Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol. 2009; 12(1):61-6. DOI: 10.1016/j.mib.2008.12.007. View

2.
Johnson A . Fluorescence approaches for determining protein conformations, interactions and mechanisms at membranes. Traffic. 2005; 6(12):1078-92. DOI: 10.1111/j.1600-0854.2005.00340.x. View

3.
Jameson D, Croney J, Moens P . Fluorescence: basic concepts, practical aspects, and some anecdotes. Methods Enzymol. 2003; 360:1-43. DOI: 10.1016/s0076-6879(03)60105-9. View

4.
Broz P, Mueller C, Muller S, Philippsen A, Sorg I, Engel A . Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol. 2007; 65(5):1311-20. DOI: 10.1111/j.1365-2958.2007.05871.x. View

5.
Lee V, Smith R, Tummler B, Lory S . Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun. 2005; 73(3):1695-705. PMC: 1064929. DOI: 10.1128/IAI.73.3.1695-1705.2005. View